Chronic Kidney Disease (CKD) / Stem Cell Therapy

Find the Best Stem Cell Treatment for Chronic Kidney Disease (CKD)
Global Stem Cells - Kidney Disease

Unique Access provides access to an extensive treatment protocol for Chronic Kidney Disease (CKD) which utilises higher quantities of stem cells, extensive rehabilitation, and many supportive therapies and supplements. This effective combination of the most advanced medical technologies with functional medicine has helped patients achieve significant improvements.

Why Stem Cells work for Chronic Kidney Disease (CKD)?

The therapeutic targets in nephrology are the reduction of injury, the delay of progression, or renal replacement therapy consisting of either renal transplantation or dialysis. Recently, new therapeutic strategies for tissue repair have emerged and one of the most promising approaches is the use of stem cells to reduce injury in Chronic Kidney Disease (CKD). Mesenchymal stem cells (MSC), based on their ability to differentiate into many types of functional cells, and anti-inflammatory properties, has emerged as the leading candidates in treating Chronic Kidney Disease (CKD).

Global Stem Cells carries extensive experience in treating chronic renal diseases using proven treatment protocols utilising Mesenchymal stem cells (MSC). We have seen great improvements in renal function and associated symptoms. Disease progression is observed to be remarkably slowed down after Mesenchymal stem cells (MSC) transplantation which significantly delays the need for dialysis and renal transplantation.

Mechanisms

Mesenchymal stem cells (MSCs) produce growth factor and cytokines that support hematopoiesis in vivo and in vitro, but Mesenchymal stem cells (MSCs) can also differentiate into a wide variety of cell lineages including renal epithelial cells, tubular cells, and can integrate into functional mesengial cells. Moreover, mesenchymal stem cells are well known for their ability to reduce the inflammatory response against the renal cells which reduce the apoptosis and increase renal function recovery.

Improvements

Most Chronic Kidney Disease (CKD) patients treated with stem cells usually observe improvements in the following areas:

  • BUN and creatinine levels normalising
  • Improved filtration
  • Balancing salts and minerals
  • Prolonging the cell death cycle
  • Slow down disease progression

Our Promise

We believe that there is always real hope and that patients deserve access to effective and safe treatments. We are independent with an in-house medical department. We combine internationally accredited hospitals, next generation treatments, unique products and services that are integrative and effective to ensure best possible treatment results.

In terms of stem cells we will make sure that the patient will receive the correct and necessary stem cell type, quality, quantity and viability. Our exclusive research partner guarantee a stem cell viability of 95%, many injections have a staggering viability of 98-99%.

We are going to make sure the patient gets the supportive remedies, therapies, rehabilitation, detox & immune-boost programmes needed to get the most out of the stem cells.

  • Hyperbaric Oxygen Chamber (HBOT)
  • Acupuncture
  • Aquatic Therapy
  • Physiotherapy Treatment
  • Occupational Therapy
  • Transcranial Magnetic Stimulation (rTMS)
  • Hemo Oxygen Therapy (HOT)
  • IV Vitamin Drips
  • Immune-Boosting Supplements (e.g. GcMAF)
  • Special Diet Plans & Consultations

The treatment will take place in an internationally accredited tertiary care hospital and not in a hotel or clinic. This is important for the patient’s safety and care as the patient will have access to all specialized departments & specialist doctors which will further increase the treatments efficiency.

The Very Best Stem Cell Treatments via globalstemcells.com

Global Stem Cells - List of improvements
What is Chronic Kidney Disease?

Chronic Kidney Disease (CKD), a progressive loss of renal function over a period of months or years, is a leading cause of mortality and morbidity in western countries that is estimated to affect 11% of the adult population. It can progress towards End-stage Renal Disease (ESRD), which has no cure and requires renal replacement therapy, that is, dialysis or renal transplantation.

Chronic Kidney Disease (CKD) results from more unremitting causes such as diabetes, hypertension, chronic infection, glomerulonephritis and interstitial nephritis, vasculitis, and congenital disorders. The signs and symptoms are that of associated with higher levels of blood urea and creatinine that include fatigue, fluid retention in lower limbs (edema), troubled concentration, lack of appetite, and dry and itchy skin.

Complications of Chronic Kidney Disease

The major complications of Chronic Kidney Disease (CKD) include severe fluid retention including into lungs (pulmonary edema), cardiovascular diseases, weak bones and increased frequency of fractures, impotence, central nervous system complications, and sudden changes in blood electrolyte levels, especially potassium, which would be life threatening in some cases.

  • Meguid El Nahas, A. and Bello, A.K. (2005) Chronic kidney disease: the global challenge.
    Lancet 365, 331–340
  • Bosan IB. Recommendations for early diagnosis of chronic kidney disease.
    Ann Afr Med 2007; 6:130–136.
  • Oldrizzi L. Collaboration between nephrologists, cardiologists and diabetologists and the importance of early diagnosis of CKD.
    G Ital Nefrol 2008; 25:8–13.
  • Freedman BI, Sedor JR. Hypertension-associated kidney disease: perhaps no more.
    J Am Soc Nephrol 2008; 19:2047–2051.
  • ookmaaker MB, MC Verhaar, AJ van Zonneveld, and TJ Rabelink. (2004). Progenitor cells in the kidney: biology and therapeutic prospectives.
    Kidney Int 66: 518−522.
  • Brodie JC and HD Humes. (2005). Stem cell approaches for the treatment of renal failure.
    Pharmacol Rev 57:299−313.
  • Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1998). Multilinease potential of adult human mesenchymal stem cells.
    Science 284:143–147.
  • Ninichuk V, O Gross, S Segerer, R Hoffmann, E Radomska, A Buchstaller, R Huss, N Akis, D Schlondorff and HJ Anders. (2006). Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen 4A3-deficient mice.
    Kidney Int 70:121−129.
  • Harris DT.Cord blood stem cells: a review of potential neurological applications.
    Stem Cell Rev. 2008,4(4):269-74.